[HTML][HTML] Receptor tyrosine kinase-targeted cancer therapy

T Yamaoka, S Kusumoto, K Ando, M Ohba… - International journal of …, 2018 - mdpi.com
In the past two decades, several molecular targeted inhibitors have been developed and
evaluated clinically to improve the survival of patients with cancer. Molecular targeted …

[HTML][HTML] Receptor Tyrosine Kinase-Targeted Cancer Therapy

T Yamaoka, S Kusumoto, K Ando, M Ohba… - International Journal of …, 2018 - ncbi.nlm.nih.gov
In the past two decades, several molecular targeted inhibitors have been developed and
evaluated clinically to improve the survival of patients with cancer. Molecular targeted …

Receptor Tyrosine Kinase-Targeted Cancer Therapy

T Yamaoka, S Kusumoto, K Ando… - … Journal of Molecular …, 2018 - search.proquest.com
In the past two decades, several molecular targeted inhibitors have been developed and
evaluated clinically to improve the survival of patients with cancer. Molecular targeted …

Receptor Tyrosine Kinase-Targeted Cancer Therapy

T Yamaoka, S Kusumoto, K Ando… - International …, 2018 - pubmed.ncbi.nlm.nih.gov
In the past two decades, several molecular targeted inhibitors have been developed and
evaluated clinically to improve the survival of patients with cancer. Molecular targeted …

[引用][C] Receptor Tyrosine Kinase-Targeted Cancer Therapy

T Yamaoka, S Kusumoto, K Ando, M Ohba… - International Journal of …, 2018 - jglobal.jst.go.jp
Receptor Tyrosine Kinase-Targeted Cancer Therapy | Article Information | J-GLOBAL Art J-GLOBAL
ID:201902244940909387 Reference number:19A1280152 Receptor Tyrosine Kinase-Targeted …

[PDF][PDF] Receptor Tyrosine Kinase-Targeted Cancer Therapy

T Yamaoka, S Kusumoto, K Ando, M Ohba… - Int. J. Mol …, 2018 - scholar.archive.org
In the past two decades, several molecular targeted inhibitors have been developed and
evaluated clinically to improve the survival of patients with cancer. Molecular targeted …

Receptor Tyrosine Kinase-Targeted Cancer Therapy.

T Yamaoka, S Kusumoto, K Ando, M Ohba… - International Journal of …, 2018 - europepmc.org
In the past two decades, several molecular targeted inhibitors have been developed and
evaluated clinically to improve the survival of patients with cancer. Molecular targeted …

Receptor Tyrosine Kinase-Targeted Cancer Therapy

T Yamaoka, S Kusumoto, K Ando, M Ohba… - International Journal of …, 2018 - cir.nii.ac.jp
抄録< jats: p> In the past two decades, several molecular targeted inhibitors have been
developed and evaluated clinically to improve the survival of patients with cancer. Molecular …

Receptor Tyrosine Kinase-Targeted Cancer Therapy

T Yamaoka, S Kusumoto, K Ando, M Ohba, T Ohmori - 2018 - agris.fao.org
In the past two decades, several molecular targeted inhibitors have been developed and
evaluated clinically to improve the survival of patients with cancer. Molecular targeted …

[PDF][PDF] Receptor Tyrosine Kinase-Targeted Cancer Therapy

T Yamaoka, S Kusumoto, K Ando, M Ohba… - Int. J. Mol …, 2018 - pdfs.semanticscholar.org
In the past two decades, several molecular targeted inhibitors have been developed and
evaluated clinically to improve the survival of patients with cancer. Molecular targeted …